National and Kapodistrian University of Athens
Η έκφραση των υποδοχέων PPAR-γ σε νεοπλάσματα μαλακών μορίων
Abstract
dc:descriptionIntroduction : Sarcoma is a very heterogenic group of malignancies that havedifferent prognosis and therapeutic approaches according to their location and theirgrade (histologic classification of malignancy). During the past decades there was adiscovery of nuclear receptors that seem to be regulating the cell cycle (differentiationor apoptosis) and some studies discovered a relationship between the peroxisomeproliferator activator receptors and cancer. As it is the case with other cancers thereseems to be a relation between PPAR-γ and sarcomas according to the publishedpapers but there has not been an evaluation of expression of PPARγ protein in softtissuetumors which is the purpose of this study.Materials and Method : We examined 44 tissue samples from patients that wereoperated with sarcoma. In collaboration with the Currie Institute in Paris and usingimmunochemistry methods we recorded the expression of the PPARγ protein in thesesamples and we tried to find if there is a relation with the clinical course of thepatients. We recorded the expression of the PPAR γ in two ways: as a percentage ofthe cells presenting this protein out of the total number of cells in the opticalmicroscope and as far as it concerns the intensity of the fluerecence it was describedon a scale of 1 to 3. Then we performed statistical analysis of the results to see if thereis a relation between the PPARγ expressed and the patients’ outcome.Results : We discovered that there is a relation between protein PPARγ expressionand the GRADE of the tumor. The patients with grade 2 or 3 disease had more proteinPPARγ expressed and their course was worst than patients with grade 1 disease. Therelationship between the percentage of PPARγ in patients with grade 1 disease andbetween those with grade 2 or grade 3 disease was analyzed with Pearson X2 test andresulted a P=0.010. The analysis of the immunostaining intensity was tested with ttestfor equality of means and produced a P = 0.024.Conclusion : Under these circumstances we believe that the PPARγ could function asa prognostic marker or substrate for possible new therapies for patients with sarcomain the future and needs to be further evaluated in the future studies.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2013
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Saliveros, Apostolos
- Σαλίβερος, Απόστολος
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39414